project id: TCGA-ACC; case submitter id: TCGA-OR-A5L9; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.72; rna integrity number: 7.9; age at index: 53; days to birth: -19526; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19526; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 871.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/1; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 10.0; sample id: 810b23d4-b8d6-41e3-8bc1-a46aa201453c; sample submitter id: TCGA-OR-A5L9-01A; portion id: ec6eec62-802d-4301-979c-1c7876fbad44; portion submitter id: TCGA-OR-A5L9-01A-11; slide id: 25d15d1c-a5e5-4dbe-ac0c-7dcc5a38bc7f; slide submitter id: TCGA-OR-A5L9-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;